|
1
|
Gupta RA, Shah N, Wang KC, Kim J, Horlings
HM, Wong DJ, Tsai MC, Hung T, Argani P, Rinn JL, et al: Long
non-coding RNA HOTAIR reprograms chromatin state to promote cancer
metastasis. Nature. 464:1071–1076. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Kogo R, Shimamura T, Mimori K, Kawahara K,
Imoto S, Sudo T, Tanaka F, Shibata K, Suzuki A, Komune S, et al:
Long noncoding RNA HOTAIR regulates polycomb-dependent chromatin
modification and is associated with poor prognosis in colorectal
cancers. Cancer Res. 71:6320–6326. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Nakagawa T, Endo H, Yokoyama M, Abe J,
Tamai K, Tanaka N, Sato I, Takahashi S, Kondo T and Satoh K: Large
noncoding RNA HOTAIR enhances aggressive biological behavior and is
associated with short disease-free survival in human non-small cell
lung cancer. Biochem Biophys Res Commun. 436:319–324. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Endo H, Shiroki T, Nakagawa T, Yokoyama M,
Tamai K, Yamanami H, Fujiya T, Sato I, Yamaguchi K, Tanaka N, et
al: Enhanced expression of long non-coding RNA HOTAIR is associated
with the development of gastric cancer. PLoS One. 8:e770702013.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Heubach J, Monsior J, Deenen R, Niegisch
G, Szarvas T, Niedworok C, Schulz WA and Hoffmann MJ: The long
noncoding RNA HOTAIR has tissue and cell type-dependent effects on
HOX gene expression and phenotype of urothelial cancer cells. Mol
Cancer. 14:1082015. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Chatterjee R and Mitra A: An overview of
effective therapies and recent advances in biomarkers for chronic
liver diseases and associated liver cancer. Int Immunopharmacol.
24:335–345. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Ishibashi M, Kogo R, Shibata K, Sawada G,
Takahashi Y, Kurashige J, Akiyoshi S, Sasaki S, Iwaya T, Sudo T, et
al: Clinical significance of the expression of long non-coding RNA
HOTAIR in primary hepatocellular carcinoma. Oncol Rep. 29:946–950.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Gao JZ, Li J, Du JL and Li XL: Long
non-coding RNA HOTAIR is a marker for hepatocellular carcinoma
progression and tumor recurrence. Oncol Lett. 11:1791–1798.
2016.PubMed/NCBI
|
|
9
|
Su DN, Wu SP, Chen HT and He JH: HOTAIR, a
long non-coding RNA driver of malignancy whose expression is
activated by FOXC1, negatively regulates miRNA-1 in hepatocellular
carcinoma. Oncol Lett. 12:4061–4067. 2016.PubMed/NCBI
|
|
10
|
Fu WM, Zhu X, Wang WM, Lu YF, Hu BG, Wang
H, Liang WC, Wang SS, Ko CH, Waye MM, et al: Hotair mediates
hepatocarcinogenesis through suppressing miRNA-218 expression and
activating P14 and P16 signaling. J Hepatol. 63:886–895. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Hanahan D and Weinberg RA: Hallmarks of
cancer: The next generation. Cell. 144:646–674. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Mantovani A: Effects on in vitro tumor
growth of murine macrophages isolated from sarcoma lines differing
in immunogenicity and metastasizing capacity. Int J Cancer.
22:741–746. 1978. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Noy R and Pollard JW: Tumor-associated
macrophages: From mechanisms to therapy. Immunity. 41:49–61. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Pyzer AR, Cole L, Rosenblatt J and Avigan
DE: Myeloid-derived suppressor cells as effectors of immune
suppression in cancer. Int J Cancer. 139:1915–1926. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Hoechst B, Ormandy LA, Ballmaier M, Lehner
F, Krüger C, Manns MP, Greten TF and Korangy F: A new population of
myeloid-derived suppressor cells in hepatocellular carcinoma
patients induces CD4(+)CD25(+)Foxp3(+) T cells. Gastroenterology.
135:234–243. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Li X, Yao W, Yuan Y, Chen P, Li B, Li J,
Chu R, Song H, Xie D, Jiang X and Wang H: Targeting of
tumour-infiltrating macrophages via CCL2/CCR2 signalling as a
therapeutic strategy against hepatocellular carcinoma. Gut.
66:157–167. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Teng KY, Han J, Zhang X, Hsu SH, He S,
Wani NA, Barajas JM, Snyder LA, Frankel WL, Caligiuri MA, et al:
Blocking the CCL2-CCR2 Axis Using CCL2-Neutralizing Antibody Is an
Effective Therapy for Hepatocellular Cancer in a Mouse Model. Mol
Cancer Ther. 16:312–322. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Chang AL, Miska J, Wainwright DA, Dey M,
Rivetta CV, Yu D, Kanojia D, Pituch KC, Qiao J, Pytel P, et al:
CCL2 produced by the glioma microenvironment is essential for the
recruitment of regulatory T cells and myeloid-derived suppressor
cells. Cancer Res. 76:5671–5682. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Yoshimura T: The production of monocyte
chemoattractant protein-1 (MCP-1)/CCL2 in tumor microenvironments.
Cytokine. pii:S1043–4666. 2017.
|
|
20
|
Kadota K, Nakai Y and Shimizu K: A
weighted average difference method for detecting differentially
expressed genes from microarray data. Algorithms Mol Biol. 3:82008.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Ping D, Boekhoudt GH, Rogers EM and Boss
JM: Nuclear factor-kappa B p65 mediates the assembly and activation
of the TNF-responsive element of the murine monocyte
chemoattractant-1 gene. J Immunol. 162:727–734. 1999.PubMed/NCBI
|
|
23
|
Ueda A, Okuda K, Ohno S, Shirai A,
Igarashi T, Matsunaga K, Fukushima J, Kawamoto S, Ishigatsubo Y and
Okubo T: NF-kappa B and Sp1 regulate transcription of the human
monocyte chemoattractant protein-1 gene. J Immunol. 153:2052–2063.
1994.PubMed/NCBI
|
|
24
|
Li J, Li S, Chen Z, Wang J, Chen Y, Xu Z,
Jin M and Yu W: miR-326 reverses chemoresistance in human lung
adenocarcinoma cells by targeting specificity protein 1. Tumour
Biol. 37:13287–13294. 2016. View Article : Google Scholar : PubMed/NCBI
|
